share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

SEC announcement ·  Mar 11 09:06
Summary by Moomoo AI
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 7, 2024, Klinger acquired 1,138 shares through the exercise of derivative securities. The following day, on March 8, 2024, she sold 544 shares on the open market at a price of $99.0509 per share, resulting in a total sale value of $53,883.69. After these transactions, Klinger's direct holdings in Moderna common stock amounted to 9,267 shares.
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 7, 2024, Klinger acquired 1,138 shares through the exercise of derivative securities. The following day, on March 8, 2024, she sold 544 shares on the open market at a price of $99.0509 per share, resulting in a total sale value of $53,883.69. After these transactions, Klinger's direct holdings in Moderna common stock amounted to 9,267 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more